Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice

Life Sciences

Volumn 85, Issue 13-14, 2009, Pages 490-498

  Sasaki, Yoshiyuki ^a,b,c   Suzuki, Wataru ^b   Shimada, Tsutomu ^b   Iizuka, Seiichi ^b   Nakamura, Satoko ^c   Nagata, Mitsunobu ^b   Fujimoto, Makoto ^d   Tsuneyama, Koichi ^d   Hokao, Ryoji ^c   Miyamoto, Ken ichi ^a   Aburada, Masaki ^b  

^a Department of Hospital Pharmacy ^*  (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c Institute for Animal Reproduction   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Diabetes mellitus; Monosodium glutamate; Non alcoholic steatohepatitis; Obesity

Indexed keywords

GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONCENTRATION PROCESS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GROWTH INHIBITION; MALE; MOUSE; NEWBORN; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY;

ANIMALS; ANIMALS, NEWBORN; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD ADDITIVES; GLUCOSE; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED ICR; MICE, OBESE; SODIUM GLUTAMATE;

MUS;

EID: 70349164862     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.07.017     Document Type: Article

References (31)

1. Bernardis L.L., and Frohman L.A. Effect of lesion size in the ventromedial hypothalamus on growth hormone and insulin levels in weaning rats. Neuroendocrinology 6 5 (1970) 319-328
2. Bunyan J., Murrell E.A., and Shah P.P. The induction of obesity in rodents by means of monosodium glutamate. British Journal of Nutrition 35 1 (1976) 25-39
3. Farrigan C., and Pang K. Obesity market overview. Nature Reviews Drug Discovery 1 4 (2002) 257-258
4. Gao Q., Wolfgang M.J., Neschen S., Morino K., Horvath T.L., Shulman G.I., and Fu X.Y. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proceedings of the National Academy of Sciences of the United States of America 101 13 (2004) 4661-4666
5. Iizuka S., Suzuki W., Tabuchi M., Nagata M., Imamura S., Kobayashi Y., Kanitani M., Yanagisawa T., Kase Y., Takeda S., Aburada M., and Takahashi K.W. Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Experimental Animals 54 1 (2005) 71-83
6. Inoue S., and Murase T. Increase of postheparin plasma-lipoprotein-lipase activity in ventromedial-hypothalamic obesity in rats. International Journal of Obesity 6 3 (1982) 259-266
7. Katsuki S., Hirata Y., Horino M., Ito M., Ishimoto M., Makino M., and Hososaka A. Obesity and hyperglycemia induced in mice by goldthioglucose. Diabetes 11 3 (1962) 209-215
8. Liebelt A.R., and Perry H.J. Hypothalamic lesions associated with goldthioglucose-induced obesity. Proceedings of the Society for Experimental Biology and Medicine 95 4 (1957) 774-777
9. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., and Matsuzawa Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 9 (2001) 2094-2099
10. Marshall B.N., Barrnet J.R., and Mayer J. Hypothalamic lesions in goldthioglucose injected mice. Proceedings of the Society for Experimental Biology and Medicine 90 1 (1955) 240-244
11. Mathews C.E., and Leiter E. Rodent models for the study of diabetes. In: Kahn C.R., King G.L., Moses A.C., Weir G.C., Jacobson A.M., and Smith RJ. (Eds). Joslin's Diabetes Mellitus. Fourteenth Edition (2005), Wolters Kluwer Company, Philadelphia 291-327
12. Matsuo T., and Shino A. Induction of diabetic alterations by goldthioglucose-obesity in KK, ICR and C57BL mice. Diabetologia 8 6 (1972) 391-397
13. Matsuyama S., Oki Y., and Yokoki Y. Obesity induced by monosodium glutamate in mice. National Institute of Animal Health quarterly 13 (1972) 91-101
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
15. Millard W.J., Martin Jr. J.B., Audet J., Sagar S.M., and Martin J.B. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110 2 (1982) 540-550
16. Minokoshi Y., Saito M., and Shimizu T. Sympathetic denervation impairs response of brown adipose tissue to VMH stimulation. American Journal of Physiology 251 5 Pt 2 (1986) R1005-R1008
17. Mordes J.P., and Rossini A.A. Animal model of diabetes. American Journal of Medicine 70 2 (1981) 353-360
18. Nagata M., Suzuki W., Iizuka S., Tabuchi M., Maruyama H., Takeda S., Aburada M., and Miyamoto K. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Experimental Animals 55 2 (2006) 109-115
19. Nakanishi Y., Tsuneyama K., Fujimoto M., Salunga T.L., Nomoto K., An J.L., Takao Y., Iizuka S., Nagata M., Suzuki W., Shimada T., Aburada M., Nakano M., Selmi C., and Gershwin M.E. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. Journal of Autoimmunity 30 1-2 (2008) 42-50
20. Olney W.J. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164 880 (1969) 719-721
21. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Archives of Internal Medicine 163 4 (2003) 427-436
22. Pitombo C., Araujo E.P., De Sousa C.T., Pareja J.C., Geloneze B., and Velloso L.A. Amelioration of diet-induced diabetes by removal of visceral fat. Journal of Endocrinology 191 3 (2006) 699-706
23. Rebuffe S.M., Surwit R., Feinglos M., Kuhn C., and Rodin J. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes. Metabolism 42 11 (1993) 1405-1409
24. Ridley P.T., and Brooks F.P. Alterations in gastric secretion following hypothalamic lesions producing hyperphagia. American Journal of Physiology 209 2 (1965) 319-323
25. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., and Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 68 11 (2004) 975-981
26. Sasaki F., and Sano M. Roles of the arcuate nucleus and ovary in the maturation of growth hormone, prolactin, and nongranulated cells in the mouse adenohypophysis during postnatal development: a stereological morphometric study by electron microscopy. Endocrinology 119 4 (1986) 1682-1689
27. Scomparin D.X., Grassiolli S., Marcal A.C., Gravena C., and Andreazzi A.E. Mathias, PCF. Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium l-glutamate-obesity onset in mice. Life Sciences 79 22 (2006) 2151-2156
28. Seckl J.R., Morton N.M., Chapman K.E., and Walker B.R. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Progress in Hormone Research 59 (2004) 359-393
29. Suzuki W., Iizuka S., Tabuchi M., Funo S., Yanagisawa T., Kimura M., Sato T., Endo T., and Kawamura H. A new mouse model of spontaneous diabetes derived from ddy strain. Experimental Animals 48 3 (1999) 181-189
30. Tanaka K., Shimada M., Nakano K., and Kusunoki T. Hypothalamic lesion induced by injection of monosodium glutamate in suckling period and subsequent development of obesity. Experimental Neurology 62 1 (1978) 191-199
31. Ueda H., Ikegami H., Yamato E., Fu J., Fukada M., Shen G., Kawaguchi Y., Takekawa Y., Fujioka Y., Fujisawa T., Nakagawa Y., Hamada Y., Shibata M., and Ogihara T. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38 5 (1995) 503-508